Skip to Content

Sparlon Approval Status

  • FDA approved: No
  • Brand name: Sparlon
  • Generic name: modafinil
  • Dosage form: Tablets
  • Previous name: Attenace
  • Company: Cephalon, Inc.
  • Treatment for: ADHD in Children and Adolescents

Development Status and FDA Approval Process for Sparlon

Aug  9, 2006Cephalon Receives Non-Approvable Letter on Sparlon
Mar 23, 2006FDA Advisory Committee Recommends Against Approval of Sparlon for Attention Deficit/Hyperactivity Disorder in Children and Adolescents
Jan 25, 2006Cephalon, Inc. Provides Update on Regulatory Status of Sparlon
Oct 21, 2005Cephalon Receives Approvable Letter for Sparlon for the Treatment of ADHD in Children and Adolescents
Dec 21, 2004Cephalon Files Application for Marketing Approval of New Modafinil Formulation for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.